Nuclease-Mediated Genome Editing

Patent No. EP3283625 (titled "Nuclease-Mediated Genome Editing") was filed by Wageningen Universiteit on Apr 15, 2016. The application was issued on Dec 11, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLESep 11, 2020CARPMAELS & RANSFORD
STRAWMANSep 10, 2020POTTER CLARKSON
BOULT WADE TENNANTMar 11, 2020BOULT WADE TENNANT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3283625

WAGENINGEN UNIVERSITEIT
Application Number
EP16724290A
Filing Date
Apr 15, 2016
Status
Revoked
Jul 4, 2025
Publication Date
Dec 11, 2019